Barclays PLC Avita Medical, Inc. Transaction History
Barclays PLC
- $353 Billion
- Q1 2025
A detailed history of Barclays PLC transactions in Avita Medical, Inc. stock. As of the latest transaction made, Barclays PLC holds 28,793 shares of RCEL stock, worth $158,361. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,793
Previous 41,029
29.82%
Holding current value
$158,361
Previous $525,000
55.43%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding RCEL
# of Institutions
76Shares Held
6.97MCall Options Held
36.4KPut Options Held
26K-
Black Rock Inc. New York, NY1.78MShares$9.81 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.43MShares$7.89 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA620KShares$3.41 Million0.0% of portfolio
-
State Street Corp Boston, MA527KShares$2.9 Million0.0% of portfolio
-
Opaleye Management Inc. Boston, MA440KShares$2.42 Million0.98% of portfolio
About AVITA Medical, Inc.
- Ticker RCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 25,030,900
- Market Cap $138M
- Description
- AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and prop...